Octopus Biosafety (STU:OCR) Selling, General, & Admin. Expense: €0.00 Mil (TTM As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:OCR Octopus Biosafety STU:OCR
6 GF Score
Price €0.10
GF Value €0.05
! 2 Warning Signs
View Full Analysis

What is Octopus Biosafety Selling, General, & Admin. Expense?

Octopus Biosafety STU:OCR 6 Selling, General, & Admin. Expense is €0.00 Mil as of Dec. 2024. GuruFocus rates STU:OCR with a GF Score™ of 6/100 and a GF Value™ of €0.05. The stock has 2 warning signs investors should review.

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Octopus Biosafety's selling, general, & admin. expense for the six months ended in Dec. 2024 was €0.00 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.


Octopus Biosafety  (STU:OCR) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Octopus Biosafety Selling, General, & Admin. Expense Related Terms


Octopus Biosafety Selling, General, & Admin. Expense Historical Data

* Premium members only.

The historical data trend for Octopus Biosafety's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Octopus Biosafety Selling, General, & Admin. Expense Chart

Octopus Biosafety Annual Data
Trend Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Selling, General, & Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Octopus Biosafety Semi-Annual Data
Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STU:OCR vs DELL, ANET, SNDK: Selling, General, & Admin. Expense Comparison

For the Computer Hardware subindustry, Octopus Biosafety's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Octopus Biosafety Selling, General, & Admin. Expense vs Hardware Industry

For the Hardware industry and Technology sector, Octopus Biosafety's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Octopus Biosafety's Selling, General, & Admin. Expense falls into.


STU:OCR
6GF Score
Octopus Biosafety STU:OCR
Selling, General, & Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Octopus Biosafety Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Selling, General, & Admin. Expense of €0.00 Mil mean?
Octopus Biosafety (STU:OCR) has a Selling, General, & Admin. Expense of €0.00 Mil as of Dec. 2024. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Octopus Biosafety and its competitors.
Is Octopus Biosafety's Selling, General, & Admin. Expense too high?
Octopus Biosafety's current Selling, General, & Admin. Expense is €0.00 Mil. Overall, Octopus Biosafety has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's Selling, General, & Admin. Expense compare to DELL and ANET?
Octopus Biosafety's Selling, General, & Admin. Expense of €0.00 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling, General, & Admin. Expense for a Hardware company?
A good Selling, General, & Admin. Expense depends on the Hardware industry context. However, Selling, General, & Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling, General, & Admin. Expense mean?
A high Selling, General, & Admin. Expense can signal that a stock is expensive relative to its fundamentals. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Octopus Biosafety and its competitors. Octopus Biosafety's current Selling, General, & Admin. Expense is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Octopus Biosafety (STU:OCR) has a current Selling, General, & Admin. Expense of €0.00 Mil. The stock's GF Value™ is €0.05, compared to a current price of €0.10 — trading 100% above its estimated fair value. The current Selling, General, & Admin. Expense is €0.00 Mil. Octopus Biosafety's overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling, General, & Admin. Expense calculated?
Selling, General, & Admin. Expense is calculated from a company's financial statements. For Octopus Biosafety (STU:OCR), the current Selling, General, & Admin. Expense is €0.00 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Octopus Biosafety (STU:OCR) Overvalued in 2026?

Based on GuruFocus' analysis, Octopus Biosafety stock appears to be overvalued. The current stock price of €0.10 is trading 100% above its estimated GF Value™ of €0.05.

Key valuation signals for STU:OCR:

  • Selling, General, & Admin. Expense: €0.00 Mil
  • GF Value™: €0.05 vs. price of €0.10 (100% above fair value)
  • GF Score™: 6/100 with 2 warning signs

No single metric tells the full story. See the STU:OCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Octopus Biosafety Business Description

Other Exchanges MLOCT:France
Address 29 rue Saint Pierre, Cholet, FRA, 49300
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
6GF Score

Get the complete analysis for STU:OCR

Selling, General, & Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.05
GF Value